PL3448853T3 - Związki do modulowania akwaporyn - Google Patents

Związki do modulowania akwaporyn

Info

Publication number
PL3448853T3
PL3448853T3 PL17720125T PL17720125T PL3448853T3 PL 3448853 T3 PL3448853 T3 PL 3448853T3 PL 17720125 T PL17720125 T PL 17720125T PL 17720125 T PL17720125 T PL 17720125T PL 3448853 T3 PL3448853 T3 PL 3448853T3
Authority
PL
Poland
Prior art keywords
aquaporins
modulating
compounds
modulating aquaporins
Prior art date
Application number
PL17720125T
Other languages
English (en)
Polish (pl)
Inventor
Johan EVENÄS
Joakim Larsson
Klaus DREISCH
Original Assignee
Apoglyx Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apoglyx Ab filed Critical Apoglyx Ab
Publication of PL3448853T3 publication Critical patent/PL3448853T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL17720125T 2016-04-28 2017-04-28 Związki do modulowania akwaporyn PL3448853T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16167378 2016-04-28
PCT/EP2017/060148 WO2017186893A1 (en) 2016-04-28 2017-04-28 Compounds for modulating aquaporins
EP17720125.8A EP3448853B1 (en) 2016-04-28 2017-04-28 Compounds for modulating aquaporins

Publications (1)

Publication Number Publication Date
PL3448853T3 true PL3448853T3 (pl) 2022-02-28

Family

ID=55854711

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17720125T PL3448853T3 (pl) 2016-04-28 2017-04-28 Związki do modulowania akwaporyn

Country Status (12)

Country Link
US (1) US10730865B2 (enExample)
EP (1) EP3448853B1 (enExample)
JP (1) JP6921118B2 (enExample)
CA (1) CA3022195C (enExample)
DK (1) DK3448853T3 (enExample)
ES (1) ES2902409T3 (enExample)
HR (1) HRP20212031T1 (enExample)
HU (1) HUE057193T2 (enExample)
LT (1) LT3448853T (enExample)
PL (1) PL3448853T3 (enExample)
PT (1) PT3448853T (enExample)
WO (1) WO2017186893A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111393444B (zh) * 2019-01-02 2022-10-28 上海迪赛诺化学制药有限公司 一种阿巴卡韦羟基醋酸酯的制备方法
WO2025137265A1 (en) 2023-12-20 2025-06-26 Saint Michael's College, Inc. Methods and compositions for reducing gliaptosis: macroglia-induced neuronal cell death
CN118001408B (zh) * 2024-04-08 2024-06-25 北京大学 一种水通道蛋白9磷酸化抑制剂的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US333792A (en) * 1886-01-05 Stop watch
EP1615637A1 (en) * 2003-04-11 2006-01-18 Novo Nordisk A/S Pharmaceutical use of substituted 1,2,4-triazoles
GB0704394D0 (en) * 2007-03-07 2007-04-11 Senexis Ltd Compounds
JP6671382B2 (ja) 2014-10-29 2020-03-25 アポグリクス アクツィエブーラーグApoGlyx AB 特に糖尿病の治療に有用である2−(1,2,4−トリアゾール−3−イルスルファニル)−n−1,3,4−チアジアゾール−2−イルアセトアミドの誘導体

Also Published As

Publication number Publication date
PT3448853T (pt) 2021-12-30
LT3448853T (lt) 2022-01-10
HUE057193T2 (hu) 2022-04-28
ES2902409T3 (es) 2022-03-28
WO2017186893A1 (en) 2017-11-02
EP3448853B1 (en) 2021-11-17
US20190127360A1 (en) 2019-05-02
JP2019516677A (ja) 2019-06-20
JP6921118B2 (ja) 2021-08-18
US10730865B2 (en) 2020-08-04
HRP20212031T1 (hr) 2022-04-01
EP3448853A1 (en) 2019-03-06
CA3022195C (en) 2024-02-13
DK3448853T3 (da) 2021-12-06
CA3022195A1 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
IL261175B (en) Propyne-indole compounds
GB201602934D0 (en) Compounds
GB201704325D0 (en) Compounds
GB201620119D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201604020D0 (en) Compounds
SI3464336T1 (sl) Spojine
GB201619694D0 (en) Compounds
GB201610854D0 (en) Compounds
IL263228A (en) Benzoxaborole compounds
GB201608777D0 (en) Compounds
GB201613946D0 (en) Compounds
GB201604022D0 (en) Compounds
GB201604030D0 (en) Compounds
LT3448853T (lt) Junginiai, skirti akvaporinų moduliacijai
GB201702221D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201713217D0 (en) Compounds
GB201622362D0 (en) Compounds
GB201604029D0 (en) Compounds
GB201622365D0 (en) Compounds
GB201604031D0 (en) Compounds
GB201720511D0 (en) Compounds
GB201616071D0 (en) Receptor modulator compounds
GB201616072D0 (en) Receptor modulator compounds